David Roman
Stock Analyst at Goldman Sachs
(1.90)
# 3,133
Out of 5,182 analysts
66
Total ratings
36.84%
Success rate
-7.53%
Average return
Main Sectors:
Stocks Rated by David Roman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BSX Boston Scientific | Maintains: Buy | $98 → $93 | $62.82 | +48.04% | 2 | Mar 27, 2026 | |
| PODD Insulet | Maintains: Buy | $363 → $326 | $204.31 | +59.56% | 2 | Feb 19, 2026 | |
| BAX Baxter International | Maintains: Neutral | $21 → $17 | $16.68 | +1.92% | 5 | Feb 17, 2026 | |
| EW Edwards Lifesciences | Maintains: Buy | $108 → $95 | $81.05 | +17.21% | 5 | Feb 11, 2026 | |
| DOCS Doximity | Maintains: Neutral | $46 → $34 | $22.77 | +49.32% | 5 | Feb 9, 2026 | |
| MDLN Medline | Initiates: Buy | $49 | $44.28 | +10.66% | 1 | Jan 12, 2026 | |
| HQY HealthEquity | Downgrades: Sell | $89 | $84.63 | +5.16% | 4 | Jan 9, 2026 | |
| KMTS Kestra Medical Technologies | Maintains: Neutral | $22 → $25 | $19.84 | +26.01% | 3 | Dec 15, 2025 | |
| COO The Cooper Companies | Maintains: Sell | $64 → $71 | $70.17 | +1.18% | 2 | Dec 8, 2025 | |
| MDT Medtronic | Upgrades: Neutral | $81 → $111 | $86.63 | +28.13% | 2 | Nov 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $180 → $202 | $116.80 | +72.95% | 4 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $26 → $33 | $9.93 | +232.33% | 3 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $16 | $16.49 | -2.97% | 1 | Oct 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $103 | $112.77 | -8.66% | 1 | Oct 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $20 | $14.60 | +36.99% | 1 | Aug 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $19 | $9.73 | +95.27% | 1 | Aug 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $29 | $12.58 | +130.52% | 1 | Jul 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $120 → $104 | $90.89 | +14.42% | 2 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $10 | $5.27 | +89.75% | 4 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $94 → $82 | $70.35 | +16.56% | 3 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $138 → $154 | $102.87 | +49.70% | 2 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $42 → $24 | $18.61 | +28.96% | 2 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $63 → $71 | $63.57 | +11.69% | 4 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $64 → $55 | $63.79 | -13.78% | 2 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $384 → $427 | $331.54 | +28.79% | 2 | Jan 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $500 | $452.07 | +10.60% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $274 | $154.51 | +77.33% | 1 | May 30, 2024 |
Boston Scientific
Mar 27, 2026
Maintains: Buy
Price Target: $98 → $93
Current: $62.82
Upside: +48.04%
Insulet
Feb 19, 2026
Maintains: Buy
Price Target: $363 → $326
Current: $204.31
Upside: +59.56%
Baxter International
Feb 17, 2026
Maintains: Neutral
Price Target: $21 → $17
Current: $16.68
Upside: +1.92%
Edwards Lifesciences
Feb 11, 2026
Maintains: Buy
Price Target: $108 → $95
Current: $81.05
Upside: +17.21%
Doximity
Feb 9, 2026
Maintains: Neutral
Price Target: $46 → $34
Current: $22.77
Upside: +49.32%
Medline
Jan 12, 2026
Initiates: Buy
Price Target: $49
Current: $44.28
Upside: +10.66%
HealthEquity
Jan 9, 2026
Downgrades: Sell
Price Target: $89
Current: $84.63
Upside: +5.16%
Kestra Medical Technologies
Dec 15, 2025
Maintains: Neutral
Price Target: $22 → $25
Current: $19.84
Upside: +26.01%
The Cooper Companies
Dec 8, 2025
Maintains: Sell
Price Target: $64 → $71
Current: $70.17
Upside: +1.18%
Medtronic
Nov 19, 2025
Upgrades: Neutral
Price Target: $81 → $111
Current: $86.63
Upside: +28.13%
Oct 31, 2025
Maintains: Neutral
Price Target: $180 → $202
Current: $116.80
Upside: +72.95%
Oct 29, 2025
Maintains: Buy
Price Target: $26 → $33
Current: $9.93
Upside: +232.33%
Oct 1, 2025
Initiates: Neutral
Price Target: $16
Current: $16.49
Upside: -2.97%
Oct 1, 2025
Initiates: Buy
Price Target: $103
Current: $112.77
Upside: -8.66%
Aug 25, 2025
Initiates: Buy
Price Target: $20
Current: $14.60
Upside: +36.99%
Aug 18, 2025
Initiates: Buy
Price Target: $19
Current: $9.73
Upside: +95.27%
Jul 1, 2025
Initiates: Buy
Price Target: $29
Current: $12.58
Upside: +130.52%
May 6, 2025
Maintains: Neutral
Price Target: $120 → $104
Current: $90.89
Upside: +14.42%
May 1, 2025
Maintains: Buy
Price Target: $13 → $10
Current: $5.27
Upside: +89.75%
May 1, 2025
Maintains: Buy
Price Target: $94 → $82
Current: $70.35
Upside: +16.56%
Mar 4, 2025
Maintains: Buy
Price Target: $138 → $154
Current: $102.87
Upside: +49.70%
Mar 3, 2025
Maintains: Neutral
Price Target: $42 → $24
Current: $18.61
Upside: +28.96%
Mar 3, 2025
Maintains: Sell
Price Target: $63 → $71
Current: $63.57
Upside: +11.69%
Mar 3, 2025
Maintains: Buy
Price Target: $64 → $55
Current: $63.79
Upside: -13.78%
Jan 30, 2025
Maintains: Neutral
Price Target: $384 → $427
Current: $331.54
Upside: +28.79%
May 30, 2024
Initiates: Buy
Price Target: $500
Current: $452.07
Upside: +10.60%
May 30, 2024
Initiates: Buy
Price Target: $274
Current: $154.51
Upside: +77.33%